Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiyan Fu

Showing results (321-330 of 332) with videos related to

Pageof 34
Sort By:
Nature Metabolism|March 3, 2026
Early-activated extracellular matrix proteins shape the metabolic and spatial dynamics of the kidney fibrotic microenvironmentYuan Gui, Wenxue Li, Jia-Jun Liu, et al.
Nature Communications|August 2, 2025
Skeletal editing of 4-arylpyrimidines into diverse nitrogen heteroaromatics via four-atom synthonsShun Li, Yonglin Shi, Juan Tang, et al.
Molecular Metabolism|March 24, 2023
Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosisYuan Gui, Yuanyuan Wang, Zachary Palanza, et al.
BMC Geriatrics|November 7, 2024
Exploring the barriers to the development of organizational health literacy in health institutions to meet the needs of older patients from multiple perspectives: a mixed-methods studyJie Zhu, Haiyan Fu, Angela Y M Leung, et al.
The Journal of Clinical Investigation|May 7, 2024
Fibroblast expression of transmembrane protein smoothened governs microenvironment characteristics after acute kidney injuryYuan Gui, Haiyan Fu, Zachary Palanza, et al.
Iscience|October 8, 2021
The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironmentHaiyan Fu, Yuan Gui, Silvia Liu, et al.
Human Gene Therapy. Clinical Development|December 20, 2015
A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIBAaron S Meadows, F Jason Duncan, Marybeth Camboni, et al.
Diabetes & Metabolism Journal|January 28, 2026
Optimizing Early Detection of Diabetic Kidney Disease through Synergistic Biomarkers and Serum Metabolites in HumanXianke Zhou, Yuan Gui, Jia-Jun Liu, et al.
Nature Communications|August 11, 2015
Oestrogen sulfotransferase ablation sensitizes mice to sepsisXiaojuan Chai, Yan Guo, Mengxi Jiang, et al.
Human Gene Therapy. Clinical Development|April 12, 2014
Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primatesDarren A Murrey, Bartholomew J Naughton, F Jason Duncan, et al.
Pageof 34

Showing results (321-330 of 332) with videos related to

Sort By:
Pageof 34
Nature Metabolism|March 3, 2026
Early-activated extracellular matrix proteins shape the metabolic and spatial dynamics of the kidney fibrotic microenvironmentYuan Gui, Wenxue Li, Jia-Jun Liu, et al.
Nature Communications|August 2, 2025
Skeletal editing of 4-arylpyrimidines into diverse nitrogen heteroaromatics via four-atom synthonsShun Li, Yonglin Shi, Juan Tang, et al.
Molecular Metabolism|March 24, 2023
Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosisYuan Gui, Yuanyuan Wang, Zachary Palanza, et al.
BMC Geriatrics|November 7, 2024
Exploring the barriers to the development of organizational health literacy in health institutions to meet the needs of older patients from multiple perspectives: a mixed-methods studyJie Zhu, Haiyan Fu, Angela Y M Leung, et al.
The Journal of Clinical Investigation|May 7, 2024
Fibroblast expression of transmembrane protein smoothened governs microenvironment characteristics after acute kidney injuryYuan Gui, Haiyan Fu, Zachary Palanza, et al.
Iscience|October 8, 2021
The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironmentHaiyan Fu, Yuan Gui, Silvia Liu, et al.
Human Gene Therapy. Clinical Development|December 20, 2015
A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIBAaron S Meadows, F Jason Duncan, Marybeth Camboni, et al.
Diabetes & Metabolism Journal|January 28, 2026
Optimizing Early Detection of Diabetic Kidney Disease through Synergistic Biomarkers and Serum Metabolites in HumanXianke Zhou, Yuan Gui, Jia-Jun Liu, et al.
Nature Communications|August 11, 2015
Oestrogen sulfotransferase ablation sensitizes mice to sepsisXiaojuan Chai, Yan Guo, Mengxi Jiang, et al.
Human Gene Therapy. Clinical Development|April 12, 2014
Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primatesDarren A Murrey, Bartholomew J Naughton, F Jason Duncan, et al.
Pageof 34